Atlas Trials

Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression

Clinical trial NCT07672431 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07672431
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2026-09-01
Primary completion
2028-12-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.